Ninety-DayReadmission andLong-Term Mortalityin Medicare Patients(≥65 Years) TreatedWith TicagrelorVersus PrasugrelAfter PercutaneousCoronary… Chris SongDevraj SukulMilan Seth2017 год

Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)
статья из журнала